How taXonomy Pathways builds comprehensive patient journeys
In a recent webinar, the HealthVerity team including Alexa Woodward, Ph.D., Director of Strategic...
In a recent webinar, the HealthVerity team including Alexa Woodward, Ph.D., Director of Strategic...
The evolution of heart failure treatment and research Heart failure remains one of the most...
The rise of GLP-1 therapies and the evolution of obesity treatment Over 40% of adults in the U.S....
Turning claims into interoperable evidence More means more. In a world where anyone can make...
Recently, Omada Health and HealthVerity announced a press release highlighting their collaboration...
This is part three of a three-part series on the essential qualities of claims data for life...
This is part two of a three-part series (read part 1, part 3) on the essential qualities of claims...
This is part one of a three-part series (read part 2, part 3) on the essential qualities of claims...
As high-value therapies become the new norm,life sciences teams need closed claims data that...
Open claims and closed payer claims data are essential for understanding the status and activities...
In just a few years, artificial intelligence (AI) has become a trusted tool in early drug discovery. Researchers using models like AlphaFold 3, RoseTTAFold All-Atom and others, can predict protein structures, design potential compounds and simulate d...